The non-alcoholic steatohepatitis (NASH) market is projected to reach US$ 24,266.81 million by 2028 from US$ 1,631.92 million in 2021; it is expected to grow at a CAGR of 47.1% from 2021 to 2028. The Global non-alcoholic steatohepatitis (NASH) Market report by Thinking Caps is an in-depth assessment of the market value, size, challenges, drivers, opportunities, restraints, competitive...